Related references
Note: Only part of the references are listed.Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species
Frederic Raymond et al.
NUCLEIC ACIDS RESEARCH (2012)
Development of Vaccines against Visceral Leishmaniasis
Krystal J. Evans et al.
JOURNAL OF TROPICAL MEDICINE (2012)
Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani
Rashmi Bankoti et al.
JOURNAL OF TROPICAL MEDICINE (2012)
Delivery of a cocktail DNA vaccine encoding cysteine proteinases type I, II and III with solid lipid nanoparticles potentiate protective immunity against Leishmania major infection
Delaram Doroud et al.
JOURNAL OF CONTROLLED RELEASE (2011)
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
Jaya Chakravarty et al.
VACCINE (2011)
C-Terminal Domain Deletion Enhances the Protective Activity of cpa/cpb Loaded Solid Lipid Nanoparticles against Leishmania major in BALB/c Mice
Delaram Doroud et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model
Ana Nieto et al.
VETERINARY RESEARCH (2011)
Leishmaniasis vaccines: past, present and future
Farrokh Modabber
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Cationic Solid Lipid Nanoparticles Loaded by Cysteine Proteinase Genes as a Novel Anti-Leishmaniasis DNA Vaccine Delivery System: Characterization and In Vitro Evaluations
Delaram Doroud et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
Identification of regulatory T cells during experimental Leishmania infantum infection
Olivia Roos Rodrigues et al.
IMMUNOBIOLOGY (2009)
Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae
H. Azizi et al.
PARASITOLOGY (2009)
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis
Amir Mizbani et al.
VACCINE (2009)
Optimized subunit vaccine protects against experimental leishmaniasis
Sylvie Bertholet et al.
VACCINE (2009)
Leishmania infantum:: Prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice
Sima Rafati et al.
EXPERIMENTAL PARASITOLOGY (2008)
Can type-1 responses against intracellular pathogens be T helper 2 cytokine dependent?
James Alexander et al.
MICROBES AND INFECTION (2008)
SIR2-Deficient Leishmania infantam induces a defined IFN-γ/IL-10 pattern that correlates with protection
Ricardo Silvestre et al.
JOURNAL OF IMMUNOLOGY (2007)
Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells
Rhea N. Coler et al.
INFECTION AND IMMUNITY (2007)
Chemical adjuvants for plasmid DNA vaccines
John R. Greenland et al.
VACCINE (2007)
Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+ CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis
Susanne Nylen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Leishmania infantum:: Mixed T-helper-1/T-helper-2 immune response in experimentally infected BALB/c mice
Nuno Rolao et al.
EXPERIMENTAL PARASITOLOGY (2007)
Balancing immunity and pathology in visceral leishmaniasis
Amanda C. Stanley et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Immunohistological features of visceral leishmaniasis in BALB/c mice
J Carrión et al.
PARASITE IMMUNOLOGY (2006)
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
S Rafati et al.
VACCINE (2006)
Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals
L Gradoni et al.
VACCINE (2005)
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis
M Breton et al.
INFECTION AND IMMUNITY (2005)
T helper (h)1/Th2 and Leishmania:: paradox rather than paradigm
J Alexander et al.
IMMUNOLOGY LETTERS (2005)
Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis
A Khamesipour et al.
VACCINE (2005)
Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum
S Rafati et al.
VACCINE (2005)
Second-generation vaccines against leishmaniasis
RN Coler et al.
TRENDS IN PARASITOLOGY (2005)
Immunopathogenesis of infection with the visceralizing Leishmania species
ME Wilson et al.
MICROBIAL PATHOGENESIS (2005)
Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response
JE Uzonna et al.
JOURNAL OF IMMUNOLOGY (2004)
Leishmaniasis: Current status of vaccine development
B Sukumaran et al.
CURRENT MOLECULAR MEDICINE (2004)
Leishmaniasis: current situation and new perspectives
P Desjeux
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2004)
Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania
A Selvapandiyan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis
A Zadeh-Vakili et al.
VACCINE (2004)
Leishmania/HIV co-infections:: epidemiology in Europe
P Desjeux et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Both interleukin-4 (IL-4) and IL-4 receptor α signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity
S Stäger et al.
INFECTION AND IMMUNITY (2003)
Leishmania mexicana and Leishmania major:: Attenuation of wild-type parasites and vaccination with the attenuated lines
H Daneshvar et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L-infantum
I Molano et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2003)
Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis
S Rafati et al.
EXPERIMENTAL PARASITOLOGY (2003)
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
Y Belkaid et al.
NATURE (2002)
IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection
AV da Costa et al.
PARASITOLOGY INTERNATIONAL (2002)
Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination
B Papadopoulou et al.
INFECTION AND IMMUNITY (2002)
Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis
L Lachaud et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Immune elimination of Leishmania major in mice:: Implications for immune memory, vaccination, and reactivation disease
JE Uzonna et al.
JOURNAL OF IMMUNOLOGY (2001)
Clinical and experimental advances in treatment of visceral leishmaniasis
HW Murray
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major
S Rafati et al.
VACCINE (2001)
Leishmaniasis: Current status of vaccine development
E Handman
CLINICAL MICROBIOLOGY REVIEWS (2001)
Identification of Leishmania major cysteine proteinases as targets of the immune response in humans
S Rafati et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Characterization of the A2-A2rel gene cluster in Leishmania donovani:: involvement of A2 in visceralization during infection
WW Zhang et al.
MOLECULAR MICROBIOLOGY (2001)
Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms
JA Streit et al.
JOURNAL OF IMMUNOLOGY (2001)
Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis
HW Murray et al.
INFECTION AND IMMUNITY (2000)
Share Paper
